NIH Record - National Institutes of Health

NIH Provides Updates on Covid-19 Vaccine

Image
Fauci, Hepburn and Collins
From l, NIAID director Dr. Anthony Fauci, Operation Warp Speed vaccine lead Dr. Matt Hepburn and NIH director Dr. Francis Collins

Photo:  Chia-Chi Charlie Chang

Image
Fauci wearing headset sits in front of computer screen
NIAID director Dr. Anthony Fauci

Photo:  Chia-Chi Charlie Chang

Image
African-American woman in headset seated in front of computer screen
Robyn, a participant in the phase 1 vaccine trial

Photo:  Chia-Chi Charlie Chang

Image
Collins wearing headset sits in front of computer screen
NIH director Dr. Francis Collins

Photo:  Chia-Chi Charlie Chang

NIH and the biotechnology company Moderna, Inc., provided an update on mRNA-1273, an investigational Covid-19 vaccine, on the morning of July 27. That afternoon, NIH leadership participated in a social media telebriefing on the vaccine, which has now entered phase 3 testing.

On hand for the morning session were NIAID director Dr. Anthony Fauci, Operation Warp Speed vaccine lead Dr. Matt Hepburn, and NIH director Dr. Francis Collins. The trial, which will be conducted at U.S. clinical research sites, is expected to enroll approximately 30,000 adult volunteers who do not have Covid-19.

Participants in the afternoon session—streamed live on Facebook and conducted at social distance—included Collins, Fauci and Moderna president Dr. Stephen Hoge. They were joined by special guest Robyn, a participant in the phase 1 vaccine trial. She helped potential volunteers understand the clinical trials process.

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Assistant Editor: Eric Bock
Eric.Bock@nih.gov (link sends e-mail)

Staff Writer: Amber Snyder
Amber.Snyder@nih.gov (link sends e-mail)